Patents by Inventor Christine Brown

Christine Brown has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240065419
    Abstract: A method of streamlined selection and application of a makeup look involving personalized makeup look recommendations with respective step-by-step makeup routine instructions for executing a selected makeup look. A predictive model identifies one or more makeup look recommendations from a database of makeup looks to present to a user. Recommendations are generated from a combination of user demographic data, user-input preferences, social networking analytics (e.g., frequently used makeup looks among users such as “trending” makeup looks), and user behavioral history data obtained from a smart device application and a smart cosmetic device system. Each respective makeup look can be executed from a respective detailed tutorial guide comprising step-by-step instructions on how to apply cosmetic substances to achieve the respective makeup look.
    Type: Application
    Filed: July 9, 2023
    Publication date: February 29, 2024
    Applicant: HUMANOID LABS, INC
    Inventors: Sandra SOSKIC, Pia HUNTER, Kristina BROWN, Priyanka KANSE, Brett WEDEWER, Kendra IVERSON, Christine VAN ROSSUM
  • Publication number: 20240065418
    Abstract: A system for the recommendation of a makeup look to a user in response to data corresponding to a smart cosmetic device, wherein the recommended makeup look is presented to a user for application using the smart cosmetic device. The smart cosmetic device collects user behavioral history such as cosmetic substance usage (e.g., color and formula of a particular cosmetic substance), design configuration (e.g., spray canister, pen, and so on), and usage pattern (e.g., frequency of use for a particular cosmetic substance at a particular time of the day, a particular day of the week, or a particular event). Data associated with user behavioral history is processed by the system to generate at least one user-personalized makeup look recommendation for presentation to the user.
    Type: Application
    Filed: July 9, 2023
    Publication date: February 29, 2024
    Applicant: HUMANOID LABS, INC
    Inventors: Sandra SOSKIC, Pia HUNTER, Kristina BROWN, Priyanka KANSE, Brett WEDEWER, Kendra IVERSON, Christine VAN ROSSUM
  • Publication number: 20240065420
    Abstract: A system for the processing of one or more makeup look recommendations for the recommendation of a respective output makeup look recommendation, wherein the respective output makeup look recommendation is renderable in a particular rendering environment (e.g., physical world, augmented reality world, or a metaverse virtual reality world). The system allows for iterative generation of makeup look recommendations within a single rendering environment (e.g., generating new physical world makeup look recommendations from previously user-selected physical world makeup look recommendations) or interreality feedback loop generation of makeup look recommendations within a plurality of rendering environments (e.g., generating a new physical world makeup look recommendation from previously user-selected augmented reality makeup look recommendations.
    Type: Application
    Filed: July 9, 2023
    Publication date: February 29, 2024
    Applicant: HUMANOID LABS, INC
    Inventors: Sandra SOSKIC, Pia HUNTER, Kristina BROWN, Priyanka KANSE, Brett WEDEWER, Kendra IVERSON, Christine VAN ROSSUM
  • Publication number: 20240062091
    Abstract: One or more real time engines of a quantum computer provide quantum measurement information to a classical computing engine via a classical function call. The quantum computer includes a controller comprising the one or more real time engines in communication with the classical computing engine, and a quantum processor. The controller is configured to control operation of one or more components of the quantum processor. The real time engines receive a classical call response comprising an indication of a result determined via execution of a classical function by the classical computing engine based at least in part on the classical function call; and control operation of the one or more components of the quantum processor based at least in part on the result.
    Type: Application
    Filed: August 9, 2023
    Publication date: February 22, 2024
    Inventors: Natalie Christine Brown, Matthew DeCross, Ciaran Ryan-Anderson, John Peter Campora, Eli Chertkov
  • Patent number: 11690908
    Abstract: Provided herein are, inter alia, methods and compositions including T cells expressing (i) a recombinant CAR protein which includes a peptide binding site and is capable of specifically binding cancer-specific antigens and (ii) a T cell receptor specific for a viral antigen (e.g., a CMV pp65 protein). The engineered T cells provided herein may be used in combination with a viral vaccine (e.g. cytomegalovirus (CMV) Triplex Vaccine) to treat a variety of cancers. The methods described herein also permit in vivo expansion of CMV-specific CAR T cells, instead of or in addition to ex vivo expansion, avoiding excessive T cell exhaustion that results in some cases from ex vivo manufacturing.
    Type: Grant
    Filed: September 2, 2021
    Date of Patent: July 4, 2023
    Assignee: CITY OF HOPE
    Inventors: John C. Williams, Christine Brown, Don J. Diamond
  • Publication number: 20220354852
    Abstract: This disclosure relates to cells that express a chimeric antigen receptor that targets IL13R?2 and/or HER2 and methods for treating a brain tumor by administering a population of cells expressing a chimeric antigen receptor that targets IL13R?2 and/or HER2 in combination with a Wnt/?-catenin pathway modulator to a subject having a brain tumor.
    Type: Application
    Filed: May 9, 2022
    Publication date: November 10, 2022
    Applicant: CITY OF HOPE
    Inventors: Margarita GUTOVA, Michael KAHN, Christine BROWN
  • Publication number: 20220062410
    Abstract: Provided herein are, inter alia, methods and compositions including T cells expressing (i) a recombinant CAR protein which includes a peptide binding site and is capable of specifically binding cancer-specific antigens and (ii) a T cell receptor specific for a viral antigen (e.g., a CMV pp65 protein). The engineered T cells provided herein may be used in combination with a viral vaccine (e.g. cytomegalovirus (CMV) Triplex Vaccine) to treat a variety of cancers. The methods described herein also permit in vivo expansion of CMV-specific CAR T cells, instead of or in addition to ex vivo expansion, avoiding excessive T cell exhaustion that results in some cases from ex vivo manufacturing.
    Type: Application
    Filed: September 2, 2021
    Publication date: March 3, 2022
    Inventors: John C. WILLIAMS, Christine BROWN, Don J. DIAMOND
  • Patent number: 11116834
    Abstract: Provided herein are, inter alia, methods and compositions including T cells expressing (i) a recombinant CAR protein which includes a peptide binding site and is capable of specifically binding cancer-specific antigens and (ii) a T cell receptor specific for a viral antigen (e.g., a CMV pp65 protein). The engineered T cells provided herein may be used in combination with a viral vaccine (e.g. cytomegalovirus (CMV) Triplex Vaccine) to treat a variety of cancers. The methods described herein also permit in viva expansion of CMV-specific CAR T cells, instead of or in addition to ex vivo expansion, avoiding excessive T cell exhaustion that results in some cases from ex vivo manufacturing.
    Type: Grant
    Filed: October 19, 2017
    Date of Patent: September 14, 2021
    Assignee: CITY OF HOPE
    Inventors: John C. Williams, Christine Brown, Don J. Diamond
  • Publication number: 20210061879
    Abstract: Provided herein are compositions which exhibit novel therapeutic capabilities and allow to reduce the off-target effect of therapeutic antibodies. The compositions include recombinant proteins that if expressed by a T cell can efficiently recruit therapeutic antibodies to their site of action.
    Type: Application
    Filed: December 31, 2018
    Publication date: March 4, 2021
    Inventors: John C. WILLIAMS, Christine BROWN, Kurt JENKINS, Yi-Chiu KUO, Cheng-Fu KUO
  • Publication number: 20200316266
    Abstract: The silicon-reinforced stent is a specially designed stent structured and arranged with a silicon coating over the metal stent structure to maintain a firmer and longer lasting stent. The silicon may be similar to Vaseline and may also prevent plaque from further accumulating in the vein. Additionally, the silicon coating will help prevent the edges of the metal structure from collapsing, thereby ensuring that if the stent moves or comes out, the movement will cause less damage.
    Type: Application
    Filed: April 3, 2020
    Publication date: October 8, 2020
    Inventor: Kalie Christine Brown
  • Publication number: 20200277400
    Abstract: Provided herein are compositions, which exhibit diagnostic capabilities and allow to rapidly add functionality to adoptive immunotherapy. The compositions include isolated nucleic acids encoding proteins including antibody regions capable of binding compounds including a peptidyl moiety (e.g., a meditope). The recombinant proteins provided herein are useful, inter alia, for a broad variety of therapeutic and diagnostic purposes. For example, the recombinant proteins provided herein including embodiments thereof may be used as non-invasive means to characterize chimeric antigen receptor (CAR) T cells before and/or during treatment of diseases (e.g., cancer).
    Type: Application
    Filed: February 6, 2020
    Publication date: September 3, 2020
    Inventors: John C. Williams, Christine Brown
  • Patent number: 10590205
    Abstract: Provided herein are compositions, which exhibit diagnostic capabilities and allow to rapidly add functionality to adoptive immunotherapy. The compositions include isolated nucleic acids encoding proteins including antibody regions capable of binding compounds including a peptidyl moiety (e.g., a meditope). The recombinant proteins provided herein are useful, inter alia, for a broad variety of therapeutic and diagnostic purposes. For example, the recombinant proteins provided herein including embodiments thereof may be used as non-invasive means to characterize chimeric antigen receptor (CAR) T cells before and/or during treatment of diseases (e.g., cancer).
    Type: Grant
    Filed: February 15, 2017
    Date of Patent: March 17, 2020
    Assignee: CITY OF HOPE
    Inventors: John C. Williams, Christine Brown
  • Publication number: 20200054736
    Abstract: Provided herein are, inter alia, methods and compositions including T cells expressing (i) a recombinant CAR protein which includes a peptide binding site and is capable of specifically binding cancer-specific antigens and (ii) a T cell receptor specific for a viral antigen (e.g., a CMV pp65 protein). The engineered T cells provided herein may be used in combination with a viral vaccine (e.g. cytomegalovirus (CMV) Triplex Vaccine) to treat a variety of cancers. The methods described herein also permit in viva expansion of CMV-specific CAR T cells, instead of or in addition to ex vivo expansion, avoiding excessive T cell exhaustion that results in some cases from ex vivo manufacturing.
    Type: Application
    Filed: October 19, 2017
    Publication date: February 20, 2020
    Inventors: John C. WILLIAMS, Christine BROWN, Don J. DIAMOND
  • Publication number: 20170226223
    Abstract: Provided herein are compositions which exhibit novel diagnostic capabilities and allow to rapidly add functionality to adoptive immunotherapy. The compositions include isolated nucleic acids encoding proteins including antibody regions capable of binding compounds including a peptidyl moiety (e.g., a meditope). The recombinant proteins provided herein are useful, inter alia, for a broad variety of therapeutic and diagnostic purposes. For example, the recombinant proteins provided herein including embodiments thereof may be used as non-invasive means to characterize chimeric antigen receptor (CAR) T cells before and/or during treatment of diseases (e.g., cancer).
    Type: Application
    Filed: February 15, 2017
    Publication date: August 10, 2017
    Inventors: John C. Williams, Christine Brown
  • Patent number: 9574014
    Abstract: Provided herein are compositions which exhibit novel diagnostic capabilities and allow to rapidly add functionality to adoptive immunotherapy. The compositions include isolated nucleic acids encoding proteins including antibody regions capable of binding compounds including a peptidyl moiety (e.g., a meditope). The recombinant proteins provided herein are useful, inter alia, for a broad variety of therapeutic and diagnostic purposes. For example, the recombinant proteins provided herein including embodiments thereof may be used as non-invasive means to characterize chimeric antigen receptor (CAR) T cells before and/or during treatment of diseases (e.g., cancer).
    Type: Grant
    Filed: May 16, 2016
    Date of Patent: February 21, 2017
    Assignee: CITY OF HOPE
    Inventors: John C. Williams, Christine Brown
  • Publication number: 20160333114
    Abstract: Provided herein are compositions which exhibit novel diagnostic capabilities and allow to rapidly add functionality to adoptive immunotherapy. The compositions include isolated nucleic acids encoding proteins including antibody regions capable of binding compounds including a peptidyl moiety (e.g., a meditope). The recombinant proteins provided herein are useful, inter alia, for a broad variety of therapeutic and diagnostic purposes. For example, the recombinant proteins provided herein including embodiments thereof may be used as non-invasive means to characterize chimeric antigen receptor (CAR) T cells before and/or during treatment of diseases (e.g., cancer).
    Type: Application
    Filed: May 16, 2016
    Publication date: November 17, 2016
    Inventors: John C. Williams, Christine Brown
  • Patent number: 7667168
    Abstract: A stackable cooking vessel arrangement for microwave ovens wherein the arrangement comprises a plurality of plate members suspended at multiple tiers by leg support members within the cooking cavity of microwave ovens.
    Type: Grant
    Filed: July 17, 2006
    Date of Patent: February 23, 2010
    Inventor: Christine Brown Smith
  • Patent number: 7234203
    Abstract: A hinge for a folding ladder including a hinge latch movable between a locked position and an unlocked position disposed within a hinge latch cavity. The hinge latch includes a first locking portion protruding therefrom, an elongated slot formed configured to slidingly receive a hinge shaft, a first opening configured to receive a first biasing member, and a second opening configured to receive a locking member. Rotational movement of one hinge casing relative to another hinge casing is prevented by engagement of the first locking portion and locking member with a respective one of the first opening and second opening.
    Type: Grant
    Filed: August 7, 2003
    Date of Patent: June 26, 2007
    Assignee: Werner Co.
    Inventors: Brett A. Latimer, Ronald K. Burig, Christine A. Brown, David E. Plotner, John J. Fiumefreddo, Roy B. Bendickson, Joseph C. Dangrow
  • Patent number: 7165649
    Abstract: A support frame for a folding ladder, a folding ladder positioning system, and a method for installing a folding ladder, are disclosed and pertain to folding ladders disposable within an opening, such as openings in a ceiling of a house, to provide temporary access between one floor or space and another floor or space. In one aspect, a support frame includes a plurality of separable support frame plates collectively configured to circumscribe the opening and a plurality of connection sites are disposed at opposing ends of each of the plurality of separable support frame plates to facilitate connection of each support frame plate to adjacent support frame plates. The connection sites include, for example, mating locking connectors or a plurality of matching through-holes, which permit insertion of a fastening means therethrough.
    Type: Grant
    Filed: August 7, 2003
    Date of Patent: January 23, 2007
    Assignee: Werner Co.
    Inventors: Brett A. Latimer, Ronald K. Burig, Christine A. Brown, David E. Plotner, John J. Fiumefreddo, Roy B. Bendickson, David A. Winslow
  • Patent number: 6994184
    Abstract: A folding ladder is configured for installation in an opening to provide access between one floor or space and another floor or space. The folding ladder includes, in one aspect, an upper ladder section having a left ladder rail and a right ladder rail, a lower ladder section having a left ladder rail and a right ladder rail, a hinge rotatably connecting the upper ladder section ladder rails to the lower ladder section ladder rails, and a plurality of steps rotatably disposed between the upper and lower ladder rails. The plurality of steps are configured for rotation between a retracted position and a deployed position. At least one step disposed between the upper ladder rails and at least one step disposed between the lower ladder rails are linked by at least one linkage member so that each of the noted steps rotates between a retracted position and a deployed position upon rotational movement of the upper ladder section relative to the lower ladder section between a closed position and an open position.
    Type: Grant
    Filed: December 12, 2003
    Date of Patent: February 7, 2006
    Assignee: Werner Co.
    Inventors: Brett A. Latimer, Ronald K. Burig, Christine A. Brown, David E. Plotner, John J. Fiumefreddo, Roy B. Bendickson